Chembio Diagnostics, Inc. Terminates U.S. Distribution Agreement With Alere Inc.

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MEDFORD, N.Y., April 7, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care (“POC”) diagnostic tests for infectious diseases, announced today that it notified Alere Inc., formerly Inverness Medical Innovations, Inc. (“Alere”), of termination of its U.S. STAT-PAK® distribution agreement.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC